Cargando…
Gastrointestinal Findings in a Patient With COVID-19
The novel coronavirus (severe acute respiratory syndrome coronavirus 2) that causes coronavirus disease 2019 was discovered in December 2019 in Wuhan, China, and has rapidly spread across the world becoming a pandemic and disrupting societies, economies, and public health. Digestive symptoms and gas...
Autores principales: | Makar, Michael, John Pisano, Thomas, Minacapelli, Carlos D., Rustgi, Vinod |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7304537/ https://www.ncbi.nlm.nih.gov/pubmed/32637437 http://dx.doi.org/10.14309/crj.0000000000000392 |
Ejemplares similares
-
In-Hospital Mortality and Prediction in an Urban U.S. Population With COVID-19
por: Rustgi, Vinod, et al.
Publicado: (2020) -
COVID-19 status quo: Emphasis on gastrointestinal and liver manifestations
por: Bhurwal, Abhishek, et al.
Publicado: (2021) -
Reduction in Gastrointestinal Cancers in Cirrhotic Patients Receiving Rifaximin vs Lactulose Only Therapy for Hepatic Encephalopathy
por: Patel, Ankoor H, et al.
Publicado: (2023) -
The Spontaneous Regression of Primary Gastrointestinal Malignancies: An Observational Review
por: Minacapelli, Carlos D, et al.
Publicado: (2022) -
Surgery in Nonalcoholic Cirrhosis: Clinical Outcomes, Healthcare Utilization, and Cost Analysis
por: Tait, Christopher, et al.
Publicado: (2023)